322 related articles for article (PubMed ID: 17056371)
1. Intravitreal triamcinolone acetonide concentration after subtenon injection.
Thomas ER; Wang J; Ege E; Madsen R; Hainsworth DP
Am J Ophthalmol; 2006 Nov; 142(5):860-1. PubMed ID: 17056371
[TBL] [Abstract][Full Text] [Related]
2. Vitreous concentrations of triamcinolone acetonide in human eyes after intravitreal or subtenon injection.
Inoue M; Takeda K; Morita K; Yamada M; Tanigawara Y; Oguchi Y
Am J Ophthalmol; 2004 Dec; 138(6):1046-8. PubMed ID: 15629301
[TBL] [Abstract][Full Text] [Related]
3. Intravitreal pharmacokinetics after posterior subtenon triamcinolone acetonide injection in vitrectomized rabbit eyes.
Park HJ; Lee JE; Kim SI; Pak KY; Oum BS; Lee JS; Jung JH; Lee JE
Retina; 2014 Apr; 34(4):801-6. PubMed ID: 24077088
[TBL] [Abstract][Full Text] [Related]
4. Intraocular availability of triamcinolone acetonide after intravitreal injection.
Jonas JB
Am J Ophthalmol; 2004 Mar; 137(3):560-2. PubMed ID: 15013884
[TBL] [Abstract][Full Text] [Related]
5. Intraocular concentration and pharmacokinetics of triamcinolone acetonide after a single intravitreal injection.
Beer PM; Bakri SJ; Singh RJ; Liu W; Peters GB; Miller M
Ophthalmology; 2003 Apr; 110(4):681-6. PubMed ID: 12689886
[TBL] [Abstract][Full Text] [Related]
6. Intraocular concentration of triamcinolone acetonide after intravitreal injection in the rabbit eye.
Kamppeter BA; Cej A; Jonas JB
Ophthalmology; 2008 Aug; 115(8):1372-5. PubMed ID: 18355920
[TBL] [Abstract][Full Text] [Related]
7. Serum levels of triamcinolone acetonide after intravitreal injection.
Degenring RF; Jonas JB
Am J Ophthalmol; 2004 Jun; 137(6):1142-3. PubMed ID: 15183810
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetic study of vitreous and serum concentrations of triamcinolone acetonide after posterior sub-tenon's injection.
Kovacs K; Wagley S; Quirk MT; Ceron OM; Silva PA; Singh RJ; Gukasyan HJ; Arroyo JG
Am J Ophthalmol; 2012 May; 153(5):939-48. PubMed ID: 22310078
[TBL] [Abstract][Full Text] [Related]
9. Vitrectomy as a treatment for elevated intraocular pressure following intravitreal injection of triamcinolone acetonide.
Agrawal S; Agrawal J; Agrawal TP
Am J Ophthalmol; 2004 Oct; 138(4):679-80. PubMed ID: 15488813
[TBL] [Abstract][Full Text] [Related]
10. Vitreous concentration of triamcinolone acetonide after a single transseptal depot injection.
Silva PS; Singh RJ; Bakri SJ; Lising RS; Santiago DE; Uy HS
Ocul Immunol Inflamm; 2009; 17(3):216-20. PubMed ID: 19585367
[TBL] [Abstract][Full Text] [Related]
11. Intravitreal triamcinolone acetonide injection at the end of vitrectomy for diabetic vitreous hemorrhage: a randomized, clinical trial.
Faghihi H; Taheri A; Farahvash MS; Esfahani MR; Rajabi MT
Retina; 2008 Oct; 28(9):1241-6. PubMed ID: 18626423
[TBL] [Abstract][Full Text] [Related]
12. Micropulsed laser photocoagulation and intravitreal triamcinolone acetonide injection for the treatment of retinal angiomatous proliferation.
Roth DB; Scott IU; Gloth JM; Green SN; Yarian DL; Wheatley M
Retina; 2007; 27(9):1201-4. PubMed ID: 18046225
[TBL] [Abstract][Full Text] [Related]
13. [The pilot study of intravitreal injection of triamcinolone acetonide for treatment of retinal detachment with choroidal detachment].
Duan AL; Wang JZ; Wang NL
Zhonghua Yan Ke Za Zhi; 2005 Jul; 41(7):606-9. PubMed ID: 16080894
[TBL] [Abstract][Full Text] [Related]
14. Triamcinolone acetonide concentration of aqueous humor after decanted 20-mg intravitreal injection.
Cheng L; Banker AS; Martin M; Kozak I; Freeman WR
Ophthalmology; 2009 Jul; 116(7):1356-9. PubMed ID: 19450879
[TBL] [Abstract][Full Text] [Related]
15. Intravitreal concentration and clearance of triamcinolone acetonide in nonvitrectomized human eyes.
Mason JO; Somaiya MD; Singh RJ
Retina; 2004 Dec; 24(6):900-4. PubMed ID: 15579987
[TBL] [Abstract][Full Text] [Related]
16. Intraocular and systemic pharmacokinetics of triamcinolone acetonide after a single 40-mg posterior subtenon application.
Shen L; You Y; Sun S; Chen Y; Qu J; Cheng L
Ophthalmology; 2010 Dec; 117(12):2365-71. PubMed ID: 20678801
[TBL] [Abstract][Full Text] [Related]
17. A rabbit model for assessing the ocular barriers to the transscleral delivery of triamcinolone acetonide.
Robinson MR; Lee SS; Kim H; Kim S; Lutz RJ; Galban C; Bungay PM; Yuan P; Wang NS; Kim J; Csaky KG
Exp Eye Res; 2006 Mar; 82(3):479-87. PubMed ID: 16168412
[TBL] [Abstract][Full Text] [Related]
18. Difference in clearance of intravitreal triamcinolone acetonide between vitrectomized and nonvitrectomized eyes.
Chin HS; Park TS; Moon YS; Oh JH
Retina; 2005; 25(5):556-60. PubMed ID: 16077349
[TBL] [Abstract][Full Text] [Related]
19. Intraocular pressure after intravitreal injection of triamcinolone acetonide following vitrectomy for macular edema.
Yamashita T; Uemura A; Kita H; Sakamoto T
J Glaucoma; 2007 Mar; 16(2):220-4. PubMed ID: 17473734
[TBL] [Abstract][Full Text] [Related]
20. Quantification of sedimented triamcinolone for intravitreal injection.
Tsong JW; Persaud TO; Mansour SE
Retina; 2007; 27(9):1255-9. PubMed ID: 18046234
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
